Organon & Co.
OGN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,776,533 | $2,516,210 | $3,839,565 | $3,844,735 |
| - Cash | $672 | $599,000 | $547,000 | $675,000 |
| + Debt | $8,828,000 | $8,896,000 | $8,956,000 | $8,880,000 |
| Enterprise Value | $11,603,861 | $10,813,210 | $12,248,565 | $12,049,735 |
| Revenue | $1,602,000 | $1,594,000 | $1,513,000 | $1,592,000 |
| % Growth | 0.5% | 5.4% | -5% | – |
| Gross Profit | $857,000 | $874,000 | $841,000 | $896,000 |
| % Margin | 53.5% | 54.8% | 55.6% | 56.3% |
| EBITDA | $460,000 | $449,000 | $325,000 | $341,000 |
| % Margin | 28.7% | 28.2% | 21.5% | 21.4% |
| Net Income | $160,000 | $145,000 | $87,000 | $109,000 |
| % Margin | 10% | 9.1% | 5.8% | 6.8% |
| EPS Diluted | 0.61 | 0.56 | 0.33 | 0.42 |
| % Growth | 8.9% | 69.7% | -21.4% | – |
| Operating Cash Flow | $264,000 | $220,000 | $75,000 | $390,000 |
| Capital Expenditures | -$115,000 | -$39,000 | -$97,000 | -$132,000 |
| Free Cash Flow | $149,000 | $181,000 | -$22,000 | $258,000 |